ストックスクリーナーアプリを入手
0.379
2.55%
-0.0099
プレマーケット:
.39
0.011
+2.90%
前日終値:
$0.3889
開ける：
$0.39
24時間の取引高:
680.97K
Relative Volume:
1.08
時価総額：
$21.36M
収益：
-
当期純損益:
$-20.23M
株価収益率:
-0.6746
EPS:
-0.5618
ネットキャッシュフロー:
$-13.97M
1週間 パフォーマンス:
-9.70%
1か月 パフォーマンス:
-21.56%
6か月 パフォーマンス:
-66.16%
1年 パフォーマンス:
-76.75%
1日の値動き範囲:
$0.3612
$0.40
1週間の範囲:
$0.3612
$0.45
52週間の値動き範囲:
$0.3612
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Compare BEAT vs VEEV, TEM, BTSG, TXG, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
0.379 | 21.36M | 0 | -20.23M | -13.97M | -0.5618 |
VEEV
Veeva Systems Inc
|
274.84 | 44.50B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
82.24 | 14.93B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.02 | 11.08B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
84.11 | 10.96B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
91.98 | 7.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-20 | ダウングレード | D. Boral Capital | Buy → Hold |
| 2026-03-31 | 開始されました | B. Riley Securities | Buy |
| 2026-03-27 | 開始されました | D. Boral Capital | Buy |
| 2026-03-16 | ダウングレード | The Benchmark Company | Buy → Speculative Buy |
| 2025-12-11 | アップグレード | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | 開始されました | H.C. Wainwright | Buy |
| 2025-10-31 | 開始されました | Roth Capital | Buy |
| 2020-09-11 | 開始されました | Needham | Buy |
| 2020-09-02 | 開始されました | Robert W. Baird | Neutral |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2019-08-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-07-26 | 繰り返されました | Lake Street | Buy |
| 2018-04-26 | 繰り返されました | The Benchmark Company | Buy |
| 2018-02-23 | 繰り返されました | Dougherty & Company | Buy |
| 2017-11-08 | 繰り返されました | Dougherty & Company | Buy |
| 2017-10-26 | 開始されました | Raymond James | Outperform |
| 2017-10-24 | 開始されました | SunTrust | Buy |
| 2017-08-09 | 繰り返されました | Dougherty & Company | Buy |
| 2017-07-19 | 繰り返されました | The Benchmark Company | Buy |
| 2017-04-11 | 繰り返されました | Dougherty & Company | Buy |
| 2016-12-02 | 開始されました | Dougherty & Company | Buy |
| 2016-09-13 | 開始されました | Sidoti | Buy |
| 2016-08-03 | 繰り返されました | The Benchmark Company | Buy |
| 2015-07-28 | 繰り返されました | Dougherty & Company | Buy |
| 2013-10-24 | 開始されました | The Benchmark Company | Buy |
| 2013-08-21 | 開始されました | Dougherty & Company | Buy |
すべてを表示
Heartbeam Inc (BEAT) 最新ニュース
HeartBeam Granted New U.S. Patent Expanding Acoustic Sensing for its ECG Device - Medical Product Outsourcing
HeartBeam (BEAT) Shifts Focus to Myocardial Infarction Detection Amid Commercialization Challenges - GuruFocus
HeartBeam shifts focus to heart attack detection technology - Investing.com
HeartBeam, Inc. Letter to Shareholders - Yahoo Finance
HeartBeam’s Heart Attack Detection Study Enrollment Completed - Medical Product Outsourcing
Heartbeam Inc. Warrant (BEATW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
BEATW Form 4 FilingsHeartbeam, Inc. Warrant SEC Form 4 - Stock Titan
Heartbeam Inc (BEAT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Heartbeam Warrant (BEATW) Plunges 32% to $0.01 as Support and Resistance Converge at Penny LevelsTrade Entry Signals - dars.gov.et
Heartbeam Inc (BEAT) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Heartbeam Inc. Warrant (BEATW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Heartbeam Warrant (BEATW) Plunges 32% to $0.01 as Speculative Value EvaporatesMax Pain Level - dars.gov.et
Heartbeam (BEATW) Today: Ends Lower by 26.67% at $0.01; Traders Can Monitor the $0.01-$0.01 Range in the Latest SessionLong Short Pair - vinanet.vn
Heartbeam (BEATW) Update: Closes with Little Net Change at $0.01 in the Latest Reading; Price Setup - vinanet.vn
Heartbeam (BEAT) Shares: Finishes 0.93% Lower at $0.48 for the Current Session; Immediate View - vinanet.vn
Price to earnings forward of Heartbeam, Inc. – BOATS:BEATW - TradingView
HeartBeam Q2 net loss hits USD 5M - Medical Buyer
HeartBeam enters $25 million at-the-market equity sales agreement with Titan Partners - Investing.com Nigeria
Form 8K Heartbeam Inc For: 14 August By Investing.com - Investing.com Australia
Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock - TradingView
Medical Journal Article Highlights Technology’s Potential to Detect Heart Attack Risk at Home - Medical Product Outsourcing
Heartbeam Inc. (BEAT) Slides 7.2% to $0.55 as Selling Pressure MountsVolatility Term Structure - Vinanet
HeartBeam, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Heartbeam Warrant (BEATW) Slides 3.6% as Shares Trade at Penny LevelsMESA MA - vinanet.vn
HeartBeam wins U.S. patent for acoustic sensing, impedance - scanx.trade
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ... - Investing.com Canada
Heartbeam earnings missed by $1.01, revenue fell short of estimates - Investing.com Canada
HeartBeam posts wider Q2 loss than expected, shares inch lower - Investing.com
HeartBeam Q2 slides show clinical progress despite wider Q2 2026 loss By Investing.com - Investing.com India
HeartBeam Q2 slides show clinical progress despite wider Q2 2026 loss - Investing.com
Why is Heartbeam stock sliding today? By Investing.com - Investing.com India
Earnings call transcript: HeartBeam stock slips after hours following Q2 results - Investing.com
BEAT: FDA pre-submission for heart attack detection and commercial rollout drive growth, with costs down - TradingView
HeartBeam Q2 Results: Net loss narrows to $5M, cash burn down 7% - scanx.trade
Transcript : HeartBeam, Inc., Q2 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
BEAT: FDA pre-submission completed, commercial rollout expands, and cash runway extended into 2027 - TradingView
HeartBeam posts wider Q2 loss than expected, shares inch lower By Investing.com - Investing.com Nigeria
HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Why is Heartbeam stock sliding today? - Investing.com
HeartBeam, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BEAT) 2026-08-13 - Seeking Alpha
HeartBeam, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
HeartBeam (BEAT): Strome group details 6.8% ownership and July–August share sales - Stock Titan
HeartBeam Q2 2026 results: Cash-burn outlook improves as net loss holds near $5 million - TradingKey
BEAT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HeartBeam (NASDAQ: BEAT) details Q2 loss, $11.5M equity raise and Nasdaq risk - Stock Titan
AUG 13 (REUTERS)HEARTBEAM Q2 BASIC EPS USD -0.1. - Moomoo
HeartBeam, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
HeartBeam Reports Second Quarter 2026 Results - Business Wire
HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Look For - Yahoo Finance
HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Lo - GuruFocus
Heartbeam Inc (BEAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Heartbeam Inc (BEAT) 財務データ
収益
当期純利益
現金流量
EPS
0.07%
2.68%
大文字化:
|
ボリューム (24 時間):